FindTrial
Sign In

Observational study on reducing the incidence and severity of adverse reactions of iodine contrast agents

Study on reducing the incidence and severity of adverse reactions of iodine contrast agents

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040275
Enrollment
Unknown
Registered
2020-11-27
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse reaction of iodine contrast agent

Interventions

Case series:Nil

Sponsors

Central China Fuwai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients expected to undergo enhanced CT examination in the radiology department

Exclusion criteria

Exclusion criteria: 1. younger than 18 years old; 2. pregnant or lactating; 3. had a prior moderate-to-severe adverse reaction to contrast media; 4. had renal dysfunction (CrCI<30 ml/min); 5. had previously participated in a similar study; 6. anticipated not being available for telephone contact or were unwilling to complete the mail-in questionnaire; 7. patients with uncontrolled hyperthyroidism.

Design outcomes

Primary

MeasureTime frame
allergic, non-allergic adverse drug reaction (physicochemical reaction);—

Countries

China

Contacts

Public ContactXie Ruigang

Zhengzhou University People's Hospital

xieruigang@163.com+86 13838004757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026